Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05783505

A Multicomponent Intervention Program to Prevent and Reduce ICU Agitation and Physical Restraint Use

PRevention of pAtient's agItation and Enhancement of Their SafEty (PRAISE): Improving Intensive Care Treatment Using a Multicomponent Pharmacological Intervention

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
480 (estimated)
Sponsor
Radboud University Medical Center · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Despite deleterious effects, physical restraints are still commonly used in (expected to become) agitated patients in Dutch ICUs (20-25%). This study aims to determine the effectiveness of a person-centered multicomponent intervention (MCI) program consisting of non-pharmacological interventions combined with goal directed light sedation using dexmedetomidine compared to the old standard of care including physical restraints in (expected to become) agitated adult ICU patients.

Detailed description

Applying physical restraints (PR) has detrimental short- and long-term effects on patients and is increasingly seen as inhumane and outdated. Nonetheless, PR are still used in approximately 20-25% of all patients during their intensive care unit (ICU) stay in the Netherlands. The aim of this study is to determine the effectiveness of a person-centered multicomponent intervention (MCI) program consisting of non-pharmacological interventions combined with goal directed light sedation using dexmedetomidine compared to the old standard of care including physical restraints on short- and long-term outcomes and healthcare costs in (expected to become) agitated adult ICU patients.

Conditions

Interventions

TypeNameDescription
OTHERMulticomponent intervention programNon-pharmacological interventions combined with goal directed sedation using dexmedetomidine if needed

Timeline

Start date
2023-06-01
Primary completion
2025-10-01
Completion
2026-10-01
First posted
2023-03-24
Last updated
2025-06-17

Locations

5 sites across 1 country: Netherlands

Source: ClinicalTrials.gov record NCT05783505. Inclusion in this directory is not an endorsement.